After years of delay, topical dapsone gel 5% can now be prescribed for patients with mild to moderate acne, marking the first new chemically based drug treatment for acne in a decade. A sulfone drug, ...

Feb. 22, 2005 (New Orleans) -- A new topical gel containing 5% dapsone is showing promise in the treatment of acne vulgaris, according to results from two studies reported here at the 63rd annual ...

Launch continues the expansion of Cosette’s generic portfolio and global partnership strategy BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. (“Cosette”), in partnership with ...

The U.S. Food and Drug Administration (FDA) has recalled 23,304 bottles of Dapsone Gel 7.5%, a popular prescription acne treatment sold under brands like Nurx and Aczone. This topical antibiotic is ...

DUBLIN, Sept. 26, 2017 /PRNewswire/ -- Today, Allergan plc (NYSE: AGN) is pleased to announce that ACZONE ® (dapsone) Gel, 7.5%, a prescription medicine used on the skin (topical) to treat acne in ...

Allergan announced the discontinuation of Aczone (dapsone) 5% 30g tubes. Allergan announced the discontinuation of Aczone (dapsone) 5% 30g tubes. The last ship date was March 31, 2016 and the ...

The Food and Drug Administration (FDA) has approved Aczone (dapsone; Almirall) Gel 7.5% for the topical treatment of acne vulgaris in patients aged ≥9 years. Previously, the treatment had been ...

The FDA has approved a new gel to treat acne. Aczone Gel 5%, made by QLT Inc., is approved to treat acne vulgaris. That's a common skin condition in which oil and dead skin cells clog the skin's pores ...

ACZONE gel 5% is the only acne treatment to harness the potential of dapsone in a topical formulation to provide patients with a convenient and effective therapy. QLT owns worldwide marketing rights ...

NEW YORK (Reuters Health) - The results of two pivotal studies demonstrate that a topical antibiotic gel sold as Aczone is safe and effective against severe blemishes and pimples go along with being a ...